Verified· 2 sources

Celluris AG

Summary

About the company

The core activity of Celluris is the development and research of personalized cancer treatments through CAR-T immunotherapy, specifically the modification of patient cells to recognize and combat tumors.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered2

CAR-T immunotherapy

CAR-T immunotherapy for the treatment of haematological and solid tumours; personalised therapy with genetically modified T cells, developed for patients who no longer respond to other therapies.

Research and development of cell therapies

Research and development in the field of cell therapy and cancer immunotherapy; development of new CAR-T approaches, including RfuCAR and accompanying preclinical tests.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Celluris AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Celluris AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Celluris AG in comparison

Industry comparisons are coming soon

Similar companies